W
WuXi XDC Cayman Inc
HKEX:2268
WuXi XDC Cayman Inc
HKEX:2268
Price:
17.3 HKD
-9.23%
Market Closed
Updated:
May 13, 2024
Section:
Relative Value
The Relative Value of one WuXi XDC Cayman Inc stock under the Base Case scenario is 6.62 HKD. Compared to the current market price of 17.3 HKD, WuXi XDC Cayman Inc is Overvalued by 62%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
6.62
HKD
Overvaluation 62%
W
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
WuXi XDC Cayman Inc Competitors
WuXi XDC Cayman Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
20.4B HKD | 19 | 121.1 | 102.7 | 123.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
228.4B USD | 5.3 | 38 | 23.5 | 34.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
186.5B USD | 4.3 | 23.2 | 16.9 | 20.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
43.2B USD | 6.4 | 35 | 27.9 | 33.6 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.7B USD | 2.8 | 30.7 | 16.9 | 26.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.2B CHF | 5.5 | 56.9 | 19.6 | 28.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | 64.8 | 34.2 | 49.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
31B USD | 8.2 | 39.8 | 27.2 | 30.3 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.1B USD | 9 | 46.2 | 32.2 | 39.1 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 3.1 | 37.5 | 17 | 26.1 | |
| US |
|
Waters Corp
NYSE:WAT
|
20.6B USD | 7.1 | 34.2 | 23 | 28.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
